Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): Lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development

Phytomedicine

Volumn 14, Issue 4, 2007, Pages 273-279

  Wu, K M ^a   Farrelly, J G ^a   Upton, R ^b   Chen, J ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b American Herbal Pharmacopoeia   (United States)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Misuse of Aristolochia related species; Nomenclature in traditional Chinese medicine (TCM); Pharmaceutical name required

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG; HERBACEOUS AGENT;

AKEBIA QUINATA; ARISTOLOCHIA; ARISTOLOCHIA DEBILIS; ARISTOLOCHIA FANGCHI; ARISTOLOCHIA HETEROPHYLLA; ARISTOLOCHIA MANSHURIENSIS; ARTICLE; CHINESE MEDICINE; CLEMATIS; CLEMATIS ARMANDII; COCCULUS; COCCULUS TRILOBUS; DRUG NOMENCLATURE; FRUIT; MENISPERMACEAE; NEPHROTOXICITY; PLANT ROOT; PLANT STEM; PRIORITY JOURNAL; RANUNCULACEAE; STEPHANIA TETRANDRA;

ARISTOLOCHIA; DRUG LABELING; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; TERMINOLOGY;

AKEBIA QUINATA; ARISTOLOCHIA; ARISTOLOCHIA DEBILIS; ARISTOLOCHIA FANGCHI; ARISTOLOCHIA HETEROPHYLLA; ARISTOLOCHIA MANSHURIENSIS; ARISTOLOCHIACEAE; CLEMATIS; COCCULUS TRILOBUS; MENISPERMACEAE; STEPHANIA TETRANDRA;

EID: 33847729819     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.05.009     Document Type: Article

References (9)

1. CFSAN/US FDA, Office of Nutritional Products, Labeling and Dietary Supplements., 2001. Letter to industry associations regarding safety concerns related to the use of botanical products containing aristolochic acid. http://www.cfsan.fda.gov/~dms/ds-botl4.html
2. Greuter, W. (Ed.), 2000. International Code of Botanical Nomenclature (St. Louis Code). Koeltz Scientific Books, Königstein (International Association for Plant Taxonomy).
3. Jiangsu New Medicine College (Ed.), 1995. A Grand Dictionary of Chinese Medicinal Herbs, third ed. Shanghai Science Technology Publishing Co., Shanghai, p. 2754.
4. SFDA/China, 2003. Suspension of Traditional Chinese Medicine Standard on Guan Mutong. China State Food and Drug Administration 2003, Notice No. 121, April 1 Announcement.
5. Upton, R., 2004. Unpublished data: American Aristolochic Acid Evaluation Project by American Herbal Pharmacopoeia.
6. Wu K.M., DeGeorge J., Atrakchi A., Barry E., Bigger A., Chen C., Du T., Freed L., Geyer H., Goheer A., Jacobs A., Jean D., Rhee H., Osterberg R., Schmidt W., and Farrelly J. A special update from the united states food and drug administration: preclinical issues and status of investigation of botanical drug products in the United States. Toxicol. Lett. 111 (2000) 199-202
7. Wu, K.M., 2002. Development of traditional Chinese medicine: use of endangered species and its protection. In: US Fish and Wildlife/Wildlife Conservation Society Symposium on "The Consensus Conference on Protecting Medicinal Plants and Animals in Oriental Medicine", New York.
8. Wu K.M., Farrelly J., Birncrant D., Chen S., Dou J., Aisar Atrakchi A., Bigger A., Chen C., Chen Z., Freed L., Ghantous H., Goheer A., Hausner E., Osterberg R., Rhee H., and Zhang K. Regulatory toxicology perspectives on the development of botanical drug products in the United States. Am. J. Ther. 11 (2004) 213-217
9. Wu, K.M., Farrelly, J., 2005. Complexities of the botanical nomenclature system in traditional Chinese medicine (TCM): lesson learned from Aristolochia and importance of the pharmaceutical name. 1:135 (O-19), FDA Science Forum.